sanofi: France’s Sanofi to seek vaccine nod after delays

Paris: French prescribed drugs large Sanofi stated on Wednesday that its Covid-19 vaccine, developed with Britain’s GSK, had delivered constructive outcomes after a 12 months of delays left it lagging behind rivals. The 2 drugmakers stated they are going to “search regulatory authorisation” for his or her vaccine in US and the EU following part 3 trials involving 1000’s of individuals. The trials indicated the vaccine was 100% efficient towards extreme Covid and hospitalisation, Sanofi stated in an announcement. It was additionally greater than 50% efficient towards all symptomatic Covid, the assertion added.